Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial.

Fitzal F, Filipits M, Rudas M, Greil R, Dietze O, Samonigg H, Lax S, Herz W, Dubsky P, Bartsch R, Kronenwett R, Gnant M.

Br J Cancer. 2015 Apr 14;112(8):1405-10. doi: 10.1038/bjc.2015.98. Epub 2015 Mar 24.

2.

Immunohistochemistry as a screening tool for ALK rearrangement in NSCLC: evaluation of five different ALK antibody clones and ALK FISH.

Hutarew G, Hauser-Kronberger C, Strasser F, Llenos IC, Dietze O.

Histopathology. 2014 Sep;65(3):398-407. doi: 10.1111/his.12399. Epub 2014 May 2.

PMID:
24612196
3.

Robust linear regression model of Ki-67 for mitotic rate in gastrointestinal stromal tumors.

Kemmerling R, Weyland D, Kiesslich T, Illig R, Klieser E, Jäger T, Dietze O, Neureiter D.

Oncol Lett. 2014 Mar;7(3):745-749. Epub 2014 Jan 15.

4.

The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer.

Filipits M, Nielsen TO, Rudas M, Greil R, Stöger H, Jakesz R, Bago-Horvath Z, Dietze O, Regitnig P, Gruber-Rossipal C, Müller-Holzner E, Singer CF, Mlineritsch B, Dubsky P, Bauernhofer T, Hubalek M, Knauer M, Trapl H, Fesl C, Schaper C, Ferree S, Liu S, Cowens JW, Gnant M; Austrian Breast and Colorectal Cancer Study Group.

Clin Cancer Res. 2014 Mar 1;20(5):1298-305. doi: 10.1158/1078-0432.CCR-13-1845. Epub 2014 Feb 11.

5.

Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1.

Heitzer E, Artl M, Filipits M, Resel M, Graf R, Weißenbacher B, Lax S, Gnant M, Wrba F, Greil R, Dietze O, Hofbauer F, Böhm G, Höfler G, Samonigg H, Schaberl-Moser R, Balic M, Dandachi N.

Mod Pathol. 2014 Jun;27(6):906-15. doi: 10.1038/modpathol.2013.204. Epub 2013 Dec 6.

6.

The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients.

Dubsky P, Brase JC, Jakesz R, Rudas M, Singer CF, Greil R, Dietze O, Luisser I, Klug E, Sedivy R, Bachner M, Mayr D, Schmidt M, Gehrmann MC, Petry C, Weber KE, Fisch K, Kronenwett R, Gnant M, Filipits M; Austrian Breast and Colorectal Cancer Study Group (ABCSG).

Br J Cancer. 2013 Dec 10;109(12):2959-64. doi: 10.1038/bjc.2013.671. Epub 2013 Oct 24.

7.

Comprehensive analysis of alterations in the miRNome in response to photodynamic treatment.

Bach D, Fuereder J, Karbiener M, Scheideler M, Ress AL, Neureiter D, Kemmerling R, Dietze O, Wiederstein M, Berr F, Plaetzer K, Kiesslich T, Pichler M.

J Photochem Photobiol B. 2013 Mar 5;120:74-81. doi: 10.1016/j.jphotobiol.2013.01.012. Epub 2013 Feb 4.

PMID:
23466801
8.

CYP2D6 metabolism and patient outcome in the Austrian Breast and Colorectal Cancer Study Group trial (ABCSG) 8.

Goetz MP, Suman VJ, Hoskin TL, Gnant M, Filipits M, Safgren SL, Kuffel M, Jakesz R, Rudas M, Greil R, Dietze O, Lang A, Offner F, Reynolds CA, Weinshilboum RM, Ames MM, Ingle JN.

Clin Cancer Res. 2013 Jan 15;19(2):500-7. doi: 10.1158/1078-0432.CCR-12-2153. Epub 2012 Dec 4.

9.

EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer.

Dubsky P, Filipits M, Jakesz R, Rudas M, Singer CF, Greil R, Dietze O, Luisser I, Klug E, Sedivy R, Bachner M, Mayr D, Schmidt M, Gehrmann MC, Petry C, Weber KE, Kronenwett R, Brase JC, Gnant M; Austrian Breast and Colorectal Cancer Study Group (ABCSG).

Ann Oncol. 2013 Mar;24(3):640-7. doi: 10.1093/annonc/mds334. Epub 2012 Oct 3.

10.

Association of stem cell marker expression pattern and survival in human biliary tract cancer.

Kemmerling R, Alinger B, Dietze O, Bösmüller HC, Ocker M, Wolkersdörfer GW, Berr F, Neureiter D, Kiesslich T.

Int J Oncol. 2012 Aug;41(2):511-22. doi: 10.3892/ijo.2012.1477. Epub 2012 May 14.

PMID:
22614781
11.

A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors.

Filipits M, Rudas M, Jakesz R, Dubsky P, Fitzal F, Singer CF, Dietze O, Greil R, Jelen A, Sevelda P, Freibauer C, Müller V, Jänicke F, Schmidt M, Kölbl H, Rody A, Kaufmann M, Schroth W, Brauch H, Schwab M, Fritz P, Weber KE, Feder IS, Hennig G, Kronenwett R, Gehrmann M, Gnant M; EP Investigators.

Clin Cancer Res. 2011 Sep 15;17(18):6012-20. doi: 10.1158/1078-0432.CCR-11-0926. Epub 2011 Aug 1.

12.

Primary testicular lymphoma: a strictly homogeneous hematological disease?

Kemmerling R, Stintzing S, Mühlmann J, Dietze O, Neureiter D.

Oncol Rep. 2010 May;23(5):1261-7.

PMID:
20372839
13.

Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy.

Filipits M, Rudas M, Heinzl H, Jakesz R, Kubista E, Lax S, Schippinger W, Dietze O, Greil R, Stiglbauer W, Kwasny W, Nader A, Stierer M, Gnant MF; Austrian Breast and Colorectal Cancer Study Group.

Clin Cancer Res. 2009 Sep 15;15(18):5888-94. doi: 10.1158/1078-0432.CCR-09-0728. Epub 2009 Sep 1.

14.

Differential diagnostic challenge of chronic neutrophilic leukemia in a patient with prolonged leukocytosis.

Neureiter D, Kemmerling R, Ocker M, Seidlhofer C, Faber V, Stöcher M, Greil R, Dietze O.

J Hematop. 2008 Jul;1(1):23-7. doi: 10.1007/s12308-008-0004-x. Epub 2008 Apr 19.

15.

Transient autoimmune hepatitis induced by a thymoma.

Aigner E, Strassburg CP, Strasser M, Pohla-Gubo G, Dietze O, Hutter J, Manns MP, Datz C.

Am J Gastroenterol. 2009 May;104(5):1332-4. doi: 10.1038/ajg.2009.99. Epub 2009 Apr 7. No abstract available.

PMID:
19352338
16.

Hedgehog signaling is involved in differentiation of normal colonic tissue rather than in tumor proliferation.

Alinger B, Kiesslich T, Datz C, Aberger F, Strasser F, Berr F, Dietze O, Kaserer K, Hauser-Kronberger C.

Virchows Arch. 2009 Apr;454(4):369-79. doi: 10.1007/s00428-009-0753-7. Epub 2009 Mar 12.

PMID:
19280222
17.

Aspects of the differential diagnosis of clear-cell lesions of the skin in connection with the rare case of a clear-cell atypical fibroxanthoma.

Kemmerling R, Dietze O, Müller S, Neureiter D.

Pathol Res Pract. 2009;205(5):365-70. doi: 10.1016/j.prp.2008.11.009. Epub 2009 Jan 19.

PMID:
19155147
18.

The expression pattern of PDX-1, SHH, Patched and Gli-1 is associated with pathological and clinical features in human pancreatic cancer.

Quint K, Stintzing S, Alinger B, Hauser-Kronberger C, Dietze O, Gahr S, Hahn EG, Ocker M, Neureiter D.

Pancreatology. 2009;9(1-2):116-26. doi: 10.1159/000178882. Epub 2008 Dec 13.

PMID:
19077462
19.

[Uncommon cystic appearance of lymph nodes in malignant lymphoma].

Hollerweger A, Macheiner P, Neureiter D, Dietze O.

Ultraschall Med. 2008 Jun;29(3):308-10. doi: 10.1055/s-2007-963660. German.

PMID:
18516772
20.

Pathways underlying iron accumulation in human nonalcoholic fatty liver disease.

Aigner E, Theurl I, Theurl M, Lederer D, Haufe H, Dietze O, Strasser M, Datz C, Weiss G.

Am J Clin Nutr. 2008 May;87(5):1374-83.

PMID:
18469261
21.

Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy.

Rudas M, Lehnert M, Huynh A, Jakesz R, Singer C, Lax S, Schippinger W, Dietze O, Greil R, Stiglbauer W, Kwasny W, Grill R, Stierer M, Gnant MF, Filipits M; Austrian Breast and Colorectal Cancer Study Group.

Clin Cancer Res. 2008 Mar 15;14(6):1767-74. doi: 10.1158/1078-0432.CCR-07-4122.

22.

bcl-2-specific siRNAs restore gemcitabine sensitivity in human pancreatic cancer cells.

Okamoto K, Ocker M, Neureiter D, Dietze O, Zopf S, Hahn EG, Herold C.

J Cell Mol Med. 2007 Mar-Apr;11(2):349-61. Epub 2007 Mar 22.

23.

Four years experience with teleneuropathology.

Hutarew G, Schlicker HU, Idriceanu C, Strasser F, Dietze O.

J Telemed Telecare. 2006;12(8):387-91.

PMID:
17227602
24.

Apoptosis, proliferation and differentiation patterns are influenced by Zebularine and SAHA in pancreatic cancer models.

Neureiter D, Zopf S, Leu T, Dietze O, Hauser-Kronberger C, Hahn EG, Herold C, Ocker M.

Scand J Gastroenterol. 2007 Jan;42(1):103-16.

PMID:
17190770
25.

[Pancreas transplant pathology: clinicopathologic and experimental findings].

Nizze H, Jonas P, Dietze O, Schareck W.

Verh Dtsch Ges Pathol. 2004;88:51-62. German.

PMID:
16892534
26.

HER2 is unlikely to be involved in directly regulating angiogenesis in human breast cancer.

Vogl G, Bartel H, Dietze O, Hauser-Kronberger C.

Appl Immunohistochem Mol Morphol. 2006 Jun;14(2):138-45.

PMID:
16785780
27.

Novel approach of human epidermal growth factor receptor 2 detection in noninvasive and invasive transitional cell carcinoma of the bladder.

Hauser-Kronberger C, Peham K, Grall J, Rausch W, Hutarew G, Dietze O.

J Urol. 2006 Mar;175(3 Pt 1):875-80; discussion 880.

PMID:
16469569
28.

Angiogenic potential of ductal carcinoma in situ (DCIS) of human breast.

Vogl G, Dietze O, Hauser-Kronberger C.

Histopathology. 2005 Dec;47(6):617-24.

PMID:
16324200
29.

Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group.

Filipits M, Pohl G, Rudas M, Dietze O, Lax S, Grill R, Pirker R, Zielinski CC, Hausmaninger H, Kubista E, Samonigg H, Jakesz R.

J Clin Oncol. 2005 Feb 20;23(6):1161-8.

PMID:
15718312
30.
31.

Comparison of real-time PCR signal-amplified in situ hybridization and conventional PCR for detection and quantification of human papillomavirus in archival cervical cancer tissue.

Biedermann K, Dandachi N, Trattner M, Vogl G, Doppelmayr H, Moré E, Staudach A, Dietze O, Hauser-Kronberger C.

J Clin Microbiol. 2004 Aug;42(8):3758-65.

32.

Comparison of an auto-stereoscopic display and polarized stereoscopic projection for macroscopic pathology.

Hutarew G, Moser K, Dietze O.

J Telemed Telecare. 2004;10(4):206-13.

PMID:
15273030
33.

High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin.

Pohl G, Rudas M, Dietze O, Lax S, Markis E, Pirker R, Zielinski CC, Hausmaninger H, Kubista E, Samonigg H, Jakesz R, Filipits M.

J Clin Oncol. 2003 Oct 1;21(19):3594-600.

PMID:
14512390
34.

Two-year evaluation of telepathology.

Hutarew G, Dandachi N, Strasser F, Prokop E, Dietze O.

J Telemed Telecare. 2003;9(4):194-9.

PMID:
12952688
35.

One 10-core prostate biopsy is superior to two sets of sextant prostate biopsies.

Fink KG, Hutarew G, Pytel A, Esterbauer B, Jungwirth A, Dietze O, Schmeller NT.

BJU Int. 2003 Sep;92(4):385-8.

36.

Evaluation of transition zone and lateral sextant biopsies for prostate cancer detection after initial sextant biopsy.

Fink KG, Hutarew G, Esterbauer B, Pytel A, Jungwirth A, Dietze O, Schmeller NT.

Urology. 2003 Apr;61(4):748-53.

PMID:
12670559
37.

[Sentinel lymph node biopsy in breast cancer patients--results and experience after 500 sentinel lymph node biopsies].

Reitsamer R, Menzel C, Peintinger F, Cimpoca W, Glück S, Sinzinger G, Rettenbacher L, Kässmann H, Hoffmann A, Prokop E, Strasser F, Kiesler J, Hutarew G, Dietze O.

Gynakol Geburtshilfliche Rundsch. 2003 Apr;43(2):98-103. German.

PMID:
12649582
38.
39.

Duodenal histology for monitoring treatment of acute rejection in pancreaticoduodenal allografts in rats.

Mark W, Hechenleitner P, Dietze O, Klima G, Schneeberger S, Steurer W, Candinas D, Margreiter R, Königsrainer A.

Transplantation. 2002 Jan 27;73(2):198-203.

PMID:
11821730
40.

Prostate cancer detection with two sets of ten-core compared with two sets of sextant biopsies.

Fink KG, Hutarew G, Lumper W, Jungwirth A, Dietze O, Schmeller NT.

Urology. 2001 Nov;58(5):735-9.

PMID:
11711351
41.

Massive progression of diffuse hepatic lymphangiomatosis after liver resection and rapid deterioration after liver transplantation.

Datz C, Graziadei IW, Dietze O, Jaschke W, Königsrainer A, Sandhofer F, Margreiter R.

Am J Gastroenterol. 2001 Apr;96(4):1278-81.

PMID:
11316184
42.

Immunohistochemical assessment of an asymptomatic glucagonoma in a patient with hypergastrinemia and marked antral angiodysplasia.

Weitgasser R, Sungler P, Hauser-Kronberger C, Dietze O, Sattlegger P, Hacker GW.

Appl Immunohistochem Mol Morphol. 2001 Mar;9(1):92-6.

PMID:
11277423
44.

Clinical relevance of HPV 16/18 testing methods in cervical squamous cell carcinoma.

Graf AH, Cheung AL, Hauser-Kornberger C, Dandachi N, Tubbs RR, Dietze O, Hacker GW.

Appl Immunohistochem Mol Morphol. 2000 Dec;8(4):300-9.

PMID:
11127922
45.

Collagenous colitis: a practically orientated approach to diagnosis.

Dietze O.

Adv Anat Pathol. 1999 Nov;6(6):327-31.

PMID:
10562895
46.

Peptidergic innervation of the human clitoris.

Hauser-Kronberger C, Cheung A, Hacker GW, Graf AH, Dietze O, Frick J.

Peptides. 1999;20(5):539-43.

PMID:
10465504
47.

Detection of human papillomavirus in cervical carcinoma: comparison of peroxidase, Nanogold, and catalyzed reporter deposition (CARD)-Nanogold in situ hybridization.

Cheung AL, Graf AH, Hauser-Kronberger C, Dietze O, Tubbs RR, Hacker GW.

Mod Pathol. 1999 Jul;12(7):689-96.

PMID:
10430273
48.

The natural course of hepatitis C virus infection 18 years after an epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis centre.

Datz C, Cramp M, Haas T, Dietze O, Nitschko H, Froesner G, Muss N, Sandhofer F, Vogel W.

Gut. 1999 Apr;44(4):563-7.

49.

p34cdc2 in invasive breast cancer: relationship to DNA content, Ki67 index and c-erbB-2 expression.

Wiesener B, Hauser-Kronberger CE, Zipperer E, Dietze O, Menzel C, Hacker GW.

Histopathology. 1998 Dec;33(6):522-30.

PMID:
9870146
50.

Post-transplantation lymphoproliferative disorder versus acute liver rejection: do we need a scoring system?

Dietze O.

Adv Anat Pathol. 1998 Jan;5(1):30-5. Review. No abstract available.

PMID:
9868511

Supplemental Content

Loading ...
Support Center